Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Epilepsy Res ; 82(1): 46-56, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18760902

ABSTRACT

Amado and Cavalheiro [Amado, D., Cavalheiro, E.A., 1998. Hormonal and gestational parameters in female rats submitted to the pilocarpine model of epilepsy. Epilepsy Res. 32, 266-274], studying the establishment of the pilocarpine epilepsy model in female rats observed that the estrous cycle was dramatically altered during the three periods of this experimental model. This work was delineated to study the function of sexual hormones in the development of the epilepsy model induced by pilocarpine in ovariectomized rats. Experimental groups were: (a) control animals during estrus phase of the estrous cycle (E) and ovariectomized female rats (OVX) treated with saline instead of pilocarpine in the same volume, (b) experimental animals, that developed status epilepticus (SE) and were studied during the chronic phase of this model: intact chronic rats (CHRON) and ovariectomized chronic rats (OVX+CHRON) and (c) ovariectomized chronic rats, that were submitted to hormonal replacement therapy treated with: medroxyprogesterone (OVX+CHRON+MPA); 17beta-estradiol (OVX+CHRON+E2), or both (OVX+CHRON+E2+MPA). All ovariectomized animals showed genital atrophy 4 days after the surgical procedure. Moreover, all animals that developed SE and survived showed spontaneous recurrent seizures during the chronic phase. Concerning to seizure frequency, animals receiving medroxyprogesterone associated with 17beta-estradiol showed decreased seizures' number. However, animals that received only medroxyprogesterone therapy also showed reduction in the number of seizures. In addition, hormonal treatment was also able to stabilize the mossy fibers sprouting process, showing the importance of these hormones in the development of the epilepsy in female rats.


Subject(s)
Epilepsy, Generalized/physiopathology , Estradiol/pharmacology , Gonadal Steroid Hormones/physiology , Hippocampus/drug effects , Hormone Replacement Therapy , Medroxyprogesterone/pharmacology , Animals , Epilepsy, Generalized/chemically induced , Estradiol/administration & dosage , Estradiol/therapeutic use , Estrus , Female , Hippocampus/physiopathology , Hypogonadism/complications , Hypogonadism/drug therapy , Hypogonadism/etiology , Medroxyprogesterone/administration & dosage , Medroxyprogesterone/therapeutic use , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/ultrastructure , Ovariectomy/adverse effects , Pilocarpine/toxicity , Rats , Rats, Wistar
2.
Epilepsy Res ; 49(3): 181-8, 2002 May.
Article in English | MEDLINE | ID: mdl-12076839

ABSTRACT

Previous studies have shown that the susceptibility to pilocarpine-induced status epilepticus (SE) in female rats changes according to estrous cycle phases. These studies have also shown that following pilocarpine administration changes occur in gonadal, hypophyseal and hypothalamic hormones that could contribute for the sequence of the epileptic events. Accordingly, the present work aimed to investigate the role of sexual hormones withdrawal on the development of the pilocarpine model of epilepsy in female rats. With this purpose, castrated and non-castrated adult female Wistar rats were injected with pilocarpine and some characteristic parameters of the experimental model were observed. The results showed increased mortality after pilocarpine injection in the castrated rats when compared with non-castrated females. The latency period for SE onset and for the first spontaneous seizure was decreased in castrated when compared with non-castrated animals. The mossy fiber sprouting measured by neo-Timm scale during the chronic period, reached grade 3 for castrated epileptic rats while the non-castrated epileptic rats showed grade 2. Our results indicate that castration interferes with the epileptogenesis in the pilocarpine model of epilepsy suggesting that female sexual hormones could have protective effects against pilocarpine-induced SE.


Subject(s)
Disease Models, Animal , Epilepsy/chemically induced , Ovariectomy/adverse effects , Pilocarpine/adverse effects , Animals , Epilepsy/metabolism , Epilepsy/prevention & control , Female , Hippocampus/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...